Literature DB >> 19690515

Generation of induced pluripotent stem cells from human beta-thalassemia fibroblast cells.

Yixuan Wang, Yonghua Jiang, Sheng Liu, Xiaofang Sun, Shaorong Gao.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19690515     DOI： 10.1038/cr.2009.100

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


× No keyword cloud information.
  19 in total

1.  Reprogramming based gene therapy for inherited red blood cell disorders.

Authors:  Xiuling Xu; Jing Qu; Keiichiro Suzuki; Mo Li; Weizhou Zhang; Guang-Hui Liu; Juan Carlos Izpisua Belmonte
Journal:  Cell Res       Date:  2012-04-03       Impact factor: 25.617

Review 2.  Induced pluripotent stem cells: emerging techniques for nuclear reprogramming.

Authors:  Ji Woong Han; Young-Sup Yoon
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

3.  Genetic correction of β-thalassemia patient-specific iPS cells and its use in improving hemoglobin production in irradiated SCID mice.

Authors:  Yixuan Wang; Chen-Guang Zheng; Yonghua Jiang; Jiqin Zhang; Jiayu Chen; Chao Yao; Qingguo Zhao; Sheng Liu; Ke Chen; Juan Du; Ze Yang; Shaorong Gao
Journal:  Cell Res       Date:  2012-02-07       Impact factor: 25.617

Review 4.  Switching cell fate: the remarkable rise of induced pluripotent stem cells and lineage reprogramming technologies.

Authors:  Vimal Selvaraj; Jennifer M Plane; Ambrose J Williams; Wenbin Deng
Journal:  Trends Biotechnol       Date:  2010-02-09       Impact factor: 19.536

5.  Induced pluripotent stem cells as a next-generation biomedical interface.

Authors:  Katherine E Hankowski; Takashi Hamazaki; Akihiro Umezawa; Naohiro Terada
Journal:  Lab Invest       Date:  2011-05-09       Impact factor: 5.662

6.  The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation.

Authors:  Xinxiu Liu; Jiayu Chen; Wenchao Liu; Xiaogang Li; Qi Chen; Tao Liu; Shaorong Gao; Min Deng
Journal:  Neurogenetics       Date:  2015-04-26       Impact factor: 2.660

Review 7.  Concise review: drug discovery in the age of the induced pluripotent stem cell.

Authors:  Huaising C Ko; Bruce D Gelb
Journal:  Stem Cells Transl Med       Date:  2014-02-03       Impact factor: 6.940

Review 8.  Human induced pluripotent stem cells for monogenic disease modelling and therapy.

Authors:  Paola Spitalieri; Valentina Rosa Talarico; Michela Murdocca; Giuseppe Novelli; Federica Sangiuolo
Journal:  World J Stem Cells       Date:  2016-04-26       Impact factor: 5.326

9.  Combining Single Strand Oligodeoxynucleotides and CRISPR/Cas9 to Correct Gene Mutations in β-Thalassemia-induced Pluripotent Stem Cells.

Authors:  Xiaohua Niu; Wenyin He; Bing Song; Zhanhui Ou; Di Fan; Yuchang Chen; Yong Fan; Xiaofang Sun
Journal:  J Biol Chem       Date:  2016-06-10       Impact factor: 5.157

10.  Naïve Induced Pluripotent Stem Cells Generated From β-Thalassemia Fibroblasts Allow Efficient Gene Correction With CRISPR/Cas9.

Authors:  Yuanyuan Yang; Xiaobai Zhang; Li Yi; Zhenzhen Hou; Jiayu Chen; Xiaochen Kou; Yanhong Zhao; Hong Wang; Xiao-Fang Sun; Cizhong Jiang; Yixuan Wang; Shaorong Gao
Journal:  Stem Cells Transl Med       Date:  2015-12-16       Impact factor: 6.940
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.